Last Week in Event SPACE: Mitsui Matsushima, L'Occitane, Prosus/Tencent, EOFlow
The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...
597 Views
Insulet Corporation: Will Its Innovative Edge In The Insulin Pump Market Last? - Major Drivers
Insulet Corporation reported an excellent first quarter of 2024 that has exceeded expectations. The demand for Omnipod 5 continues to rise, the...
376 Views
EOFlow (294090 KS): Suitably Pumped
EOFlow is free to resume global sales. Medtronic is free to reengage. I'd be buying EOFlow. Then I'd buy some more. I'd be shorting Insulet.
817 Views
Eoflow Announced that US Federal Court Has Decided to Suspend the Effect of 1st Injunction Decision
On 8 May, Eoflow announced that the U.S. federal court has decided to suspend the effect of the first injunction decision.
1.9k Views
Insulet Corporation: Is Its Strategy Of Connecting With Healthcare Professionals For Penetration In Niche Markets Working? - Major Drivers
Insulet Corporation reported strong Q4 2023 results, marking its eighth straight year of 20-plus percent revenue growth. The company's automated...
286 Views